{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:59:20Z","timestamp":1740124760029,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/bmt.2017.38","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T15:01:42Z","timestamp":1489417302000},"page":"926-928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome\u2014implication for the utility of serial biomarker monitoring"],"prefix":"10.1038","volume":"52","author":[{"given":"A T","family":"Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N N","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Anandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Chinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Muranski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-0234","authenticated-orcid":false,"given":"S","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"BFbmt201738_CR1","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"PG Richardson","year":"2016","unstructured":"Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 2016; 127: 1656\u20131665.","journal-title":"Blood"},{"key":"BFbmt201738_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","volume":"21","author":"KC Myers","year":"2015","unstructured":"Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S . Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21: 379\u2013381.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201738_CR3","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-13-3205","volume":"20","author":"AA Kennedy-Nasser","year":"2014","unstructured":"Kennedy-Nasser AA, Ku S, Castillo-Caro P, Hazrat Y, Wu MF, Liu H et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res 2014; 20: 2215\u20132225.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201738_CR4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/bmt.2016.226","volume":"51","author":"P Anandi","year":"2016","unstructured":"Anandi P, Tian X, Chinian F, Cantilena CR, Dunavin N, Hensel N et al. Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system. Bone Marrow Transplant 2016; 51: 1615\u20131616.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201738_CR5","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","volume":"21","author":"A Akil","year":"2015","unstructured":"Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015; 21: 1739\u20131745.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201738_CR6","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3109\/10428194.2012.661052","volume":"53","author":"RK Pai","year":"2012","unstructured":"Pai RK, van Besien K, Hart J, Artz AS, O\u2019Donnell PH . Clinicopathologic features of late onset veno-occlusive disease\/sinusoidal obstructive syndrome after high dose busulfan and hematopoietic cell transplantation. Leuk lymphoma 2012; 53: 1552\u20131557.","journal-title":"Leuk lymphoma"},{"key":"BFbmt201738_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/0973-1482.59910","volume":"5","author":"MS Shah","year":"2009","unstructured":"Shah MS, Jeevangi NK, Joshi A, Khattry N . Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. J Cancer Res Ther 2009; 5: 312\u2013314.","journal-title":"J Cancer Res Ther"},{"key":"BFbmt201738_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.bbmt.2014.05.022","volume":"20","author":"L Chang","year":"2014","unstructured":"Chang L, Frame D, Braun T, Gatza E, Hanauer DA, Zhao S et al. Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. Biol Blood Marrow Transplant 2014; 20: 1407\u20131417.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201738_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1213299","volume":"369","author":"MT Vander Lugt","year":"2013","unstructured":"Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med 2013; 369: 529\u2013539.","journal-title":"N Engl J Med"},{"key":"BFbmt201738_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12: 235\u2013239.","journal-title":"Nat Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201738","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:14:58Z","timestamp":1648062898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFbmt201738"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.38","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"13 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}